CR

Chita Ranjan Patra

Active Director Director DIN 08449285
DIN 08449285 First appointment Jan 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jan 2013
Shareholding value •••• Premium profile

About Chita Ranjan Patra

Data last updated:

Chita Ranjan Patra is a Director at Wekeyar Plus Pharma Private Limited (since 2019), Director at Wekeyar Druggist & Chemist Private Limited (since 2019) and Director at P C Patra And Sons Retail Private Limited (since 2013), and holds 1 more current directorship. The companies operate in Pharma, Food and Beverages and Energy and Power. The 4 current companies with reported revenue have a combined latest revenue of ₹46.50 Cr; the largest is Wekeyar Plus Pharma Private Limited at ₹18.89 Cr (FY 2024). Earlier, Chita Ranjan Patra was a Director at Wekeyar International Corporation Private Limited (2019).

DIN 08449285
Primary Designation Director
Industry Pharma
First Appointment 10 Jan 2013
Oldest Company Age 13 yrs
Largest company Wekeyar Plus Pharma Private Limited · ₹18.89 Cr (FY 2024)
Combined revenue ₹46.50 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wekeyar Plus Pharma Private Limited U51909OR2019PTC031400
Director29 Jul 20192019₹18.89 Cr (FY 2024)Active
Director30 Jul 20192019₹18.46 Cr (FY 2024)Active
Director10 Jan 20132013₹9.14 Cr (FY 2024)Active
Wekeyar Industries Private Limited U51909OR2019PTC030988
Director10 May 20192019₹67,397 (FY 2020)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Oct 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Chita Ranjan Patra

Directorship timeline

Open interactive timeline →
Wekeyar Druggist & Chemist Private Limited
Wekeyar Industries Private Limited
Wekeyar Plus Pharma Private Limited
P C Patra And Sons Retail Private Limited
Premium access

Shareholding and investment profile for Chita Ranjan Patra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chita Ranjan Patra

Chita Ranjan Patra currently holds 4 directorships: Wekeyar Plus Pharma Private Limited (Director, since 29 Jul 2019, revenue ₹18.89 Cr (FY 2024)); Wekeyar Druggist & Chemist Private Limited (Director, since 30 Jul 2019, revenue ₹18.46 Cr (FY 2024)); P C Patra And Sons Retail Private Limited (Director, since 10 Jan 2013, revenue ₹9.14 Cr (FY 2024)); Wekeyar Industries Private Limited (Director, since 10 May 2019, revenue ₹67,397 (FY 2020)).

Chita Ranjan Patra was first appointed on 10 Jan 2013 as Director at P C Patra And Sons Retail Private Limited. The most recent appointment on record is 10 Oct 2019 at Wekeyar International Corporation Private Limited.

The 4 current companies of Chita Ranjan Patra that report revenue have a combined latest revenue of ₹46.50 Cr: Wekeyar Plus Pharma Private Limited ₹18.89 Cr (FY 2024); Wekeyar Druggist & Chemist Private Limited ₹18.46 Cr (FY 2024); P C Patra And Sons Retail Private Limited ₹9.14 Cr (FY 2024); Wekeyar Industries Private Limited ₹67,397 (FY 2020).

Chita Ranjan Patra held 1 earlier board appointment: Wekeyar International Corporation Private Limited (Director, 10 Oct 2019 to 31 Dec 2019).

The current boards of Chita Ranjan Patra's companies include Jayasen Patra (Wekeyar Plus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available